TSC
ABVX icon

Two Seas Capital’s Abivax ABVX Stock Holding History

Two Seas Capital’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-266,400
Closed -$35.5M – 48
2026
Q2 		$35.5M Buy
+266,400
New +$30.2M 0.7% 25

Other funds holding ABVX

VFP
Vilga Financial Planning Fair Lawn, New Jersey $168M AUM 23.03% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GBT
Grove Bank & Trust Miami, Florida $1.01B AUM 19.76% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
EWP
Elevation Wealth Partners Santa Rosa, California $356M AUM 17.04% 1-Year Est. Return
PS
Planning Strategies Lancaster, Pennsylvania $169M AUM

Two Seas Capital's ABVX Position: Q3 2026 in Review

Two Seas Capital increased its Abivax (ABVX) stake by 177% in Q3 2026, buying an estimated $52.1M and bringing the position to 676,589 shares worth $67M. The position accounts for 0.77% of the portfolio, ranked #17.

Two Seas Capital first reported a position in ABVX in Q2 2026 and has held it in 2 quarters since. 9 funds tracked by Wall St. Rank hold ABVX as of Q3 2026.

  • Two Seas Capital held 676,589 shares of Abivax worth $67M as of Q3 2026.
  • Two Seas Capital bought 431,999 Abivax shares in Q3 2026, an estimated $52.1M.
  • Abivax made up 0.77% of Two Seas Capital's portfolio in Q3 2026, its #17 holding.
  • Two Seas Capital first reported a position in Abivax in Q2 2026 and has held it in 2 quarters since.
  • 9 funds tracked by Wall St. Rank held Abivax as of Q3 2026.

Based on Two Seas Capital's 13F filing for Q3 2026, filed 6 Oct 2026.